It has been suggested that reactive oxygen species (ROS) play a role in the pathophysiology of brain damage, A number of therapeutic approaches, based on scavenging these radicals, have been attempted both in experimental models and in the clinical setting, In an experimental rat and mouse model of closed-head injury (CHI), we have studied the total tissue nonenzymatic antioxidant capacity to combat ROS, A major mechanism for neutralizing ROS uses endogenous low molecular weight antioxidants (LMW A), This review deals with the source i\ild nature of ROS in the brain, along with the endogenous defense mechanisms that fight ROS, Special em phasis is placed on LMW A such as ascorbate, urate, tocopher ol, lipoic acid, and histidine-related compounds, A novel elec trochemical method, using cyclic voltammetry for the determi nation of total tissue LMW A, is described, The temporal changes in brain LMWA after CHI, as part of the response of the tissue to high ROS levels, and the correlation between the The physiological response to brain injury is ex tremely complex and involves the activation of an over lapping network of humoral, tissue, and cellular path ways, The initiating event (whether ischemia, mechani cal trauma, or infection) triggers the release of endogenous mediators, These, in turn, via successive am plification steps, initiate a cascade of molecular, cellular, and tissue responses resulting in delayed tissue edema, necrosis, and impaired function (Abbreviations used: apoE, apolipoprotein E; BBB, blood-brain bar rier; CHI, closed-head injury; LMW A, low-molecular weight antioxi dants; ROS, reactive oxygen species; SOD, superoxide dismutase.
elicitation of various pathological responses in the patho genesis of ischemia and trauma (Demopoulos et aI., 1980; Kontos, 1989; Siesjo et aI., 1989; Chan, 1989; Hall and Braughler, 1989; Yukido and Long, 1990; Hall et aI., 1992; Helfaer et aI., 1994) , Studies on mechanisms un derlying selective neuronal vulnerability implicate the neurotoxic action of glutamate through activation of the NMDA receptor, and blockade of this receptor is asso ciated with neuroprotection. It has been suggested that the initial events in blunt head trauma lead to a final common pathway of neuronal death involving loss of cellular calcium homeostasis, production of free radicals, and tissue acidosis (for review, see Siesjo, 1993) . A num ber of therapeutic approaches, based on intervention by scavenging ROS, have been attempted both in experi mental models (for review see McIntosh, 1993 , Hensley et aI., 1997 and in the clinical setting (for review see Wahlgren, 1997) . In addition, it was postulated that be cause of the synergism between excitotoxicity and pro oxidant events, therapeutic modalities based on com bined mechanisms of action (e.g" glutamate antagonists and antioxidants) should prove more effective than monotherapy (Kempski, 1994) .
The brain is the tissue most vulnerable to oxidative damage because of its high rate of oxidative metabolic activity, intensive production of reactive oxygen metabo lites, relatively low antioxidant capacity, low repair mechanism activity, nonreplicating nature of its neuronal cells, and the high membrane surface to cytoplasm ratio (Evans, 1993; Reiter, 1995) . The high concentrations of polyunsaturated fatty acids in the membrane lipids of the brain are the source for the decomposition reactions termed "lipid peroxidation," in which a ' single initiating free radical can precipitate the destruction of adjacent molecules (Watson, 1993) . The brain also contains high levels of transition metals, such as iron, which are lo cated in specific sites in the brain (e.g., substantia nigra). These redox-active metals are capable of catalyzing the production of highly toxic radicals via the metal mediated Haber-Weiss reaction (Halliwell and Gut teridge, 1989) . The presence of ascorbic acid in close proximity to the binding sites of the ferric ions may result in the pro-oxidant rather than in the antioxidant activity of ascorbic acid (Halliwell, \996) . Therefore, it is postulated that highly reactive oxygen radicals are continuously being produced in the brain as the result of the interaction between various transition metals and re ducing equivalents. This phenomenon is extremely im portant in brain injury when mobilization of redox-active metals may occur, followed by their exposure to reduc ing agents. The outcome of such interactions may ex plain some of the oxidative damage detected after trau matic or ischemic injury to the brain. In addition, several cell regulatory mechanisms are known or considered to be affected by oxidative stress (Hensley et aI., 1997) . Cytokine or growth factor mediated signal transduction pathways that are activated by brain trauma include tyrosine phosphorylation and activation of the resident cytosolic protein complex NF kB. Proteolytic cleavage and removal of the inhibitory peptide ikB results in translocation of the active species to the nucleus, its binding to kB-specific DNA se quences, and activation of gene transcription. Recently, Lander et al. (1995) suggested that a main oxidatively sensitive element in the NF-kB triggering cascade is a redox-modulated G protein encoded by the proto oncogene p21 ras . AP-l is another transcription factor complex, composed of c-fos and c-jun heterodimers, whose mRNA are induced by hydrogen peroxide (H202) (Amstad et aI., 1992) , and it is implicated in programmed cell death. Oxidative damage to calmodulin-regulated enzymes, resulting in dysregulation of cellular homeo stasis and intracellular transduction cascades, was re ported by Yao et ai. (1996) . Thus, ROS have been shown to affect not only "classical" targets, such as lipids and proteins, but also gene transcriptional processes associ-J Cereh Blood Flow Metab, Vol. 17, No. 10, 1997 ated with pathological events. Therefore, antioxidants may help to preserve not only membranes and enzymes, but also to suppress destructive oxidatively-sensitive gene regulatory processes.
The present review addresses the following issues:
(I) the source and nature of ROS in the brain;
(2) the endogenous defense mechanisms that fight ROS, with special emphasis on low-molecular weight antioxidants (LMW A);
(3) a novel method, based on cyclic-voltammetry, for determining total tissue reducing antioxidants;
(4) a model of closed-head injury (CHI), and the tem poral changes in brain LMW A after CHI;
(5) the correlation between the ability of the brain to increase its level of LMW A and the clinical outcome of CHI (a) elevation of endogenous LMW A after CHI in rats that have been acclimated to heat and their better recovery from injury;
(b) the impaired ability of apolipoprotein E (apoE)-deficient mice to augment LMW A after CHI, and their more sluggish recovery from injury;
(6) the cerebroprotective effects of radical neutraliz ing agents, such as an iron chelator, superoxide dismu tase, nitroxides and HU-211, a novel NMDA antagonist with antioxidant properties.
BRAIN REACTIVE OXYGEN SPECIES,

DEFENSE MECHANISMS, AND THE
CYCLICVOLTAMMETRY TECHNIQUE
Source and nature of reactive oxygen species in the brain Reacti ve oxygen species include superoxide, hy droxyl, nitric oxide, peroxyl and alkoxyl radicals, as well as nonradical oxygen metabolites such as hydrogen per oxide, lipid hydroperoxide, singlet oxygen, and hypo chlorous acid. The brain, a relatively small tissue, uses 20% of the inspired oxygen (Ames, 1983) . Although most of the oxygen molecules are consumed for the pro duction of energy in the form of A TP molecules, a small proportion (about 5%) is used in alternative pathways leading to the production of ROS. In the mitochondria, oxygen molecules are used in a complex of reactions by mitochondrial cytochrome oxidase. This enzyme com plex adds four electrons to the oxygen molecule and transforms it into two water molecules. The process, which occurs in stages, is involved in the production of ROS such as superoxide radicals (02 -;-), hydroxyl radi cals (OH') and hydrogen peroxide (H202) (Halliwell and Gutteridge, 1989) . The chain transport of electrons in the mitochondria is not absolutely efficient and, therefore, leakage of ROS from the mitochondrial organelles may occur, especially when there is an excess of oxygen (Re iter, 1995) . Other endogenous sources of ROS in the brain include enzymatic processes in which ROS are generated directly or indirectly (e.g., monoamine oxidase, nitric oxide synthase, and cyclooxygenase) and various cells such as activated neutrophils. Excitatory amino ac ids also generate high levels of ROS on their massive release after injury (Dugan and Choi, 1994) . The brain is also exposed to ROS from exogenous sources such as irradiation, pollutants that can enter the brain via blood carriers, as well as xenobiotics and drugs.
Polyunsaturated fatty acids, highly abundant in the brain, serve as a major biological target for the oxidative damage induced by ROS (Rice- Evans and Burdon, 1993; Watson 1993) . Lipid peroxidation causes damage to bio logical membranes and nerves and leads to production of secondary reactive metabolites (e.g. aldehydes). Other biological targets may be proteins, which can sustain direct damage, or chain reaction analogues of fatty acids (Stadtman, 1992) . DNA also serves as a major candidate for oxidative damage (Ames et aI., 1993) . In individuals suffering from Parkinson's disease, oxidative DNA dam age is greater within brain regions rich in dopaminergic neurons (Ames et aI., 1993; Halliwell and Gutterigde, 1990; Diplock, 1994, Youdim and Riederer, 1997) .
Endogenous defense mechanisms of the brain
To contend with the continuous exposure to ROS, the living cell has developed several lines of defense. These include preventive mechanisms against oxidative dam age, repair mechanisms, and an antioxidant defense sys tem. The latter assists the living cell to cope directly with ROS and to prevent oxidative damage. It would be ex pected that the brain, which is particularly vulnerable to oxidative damage, possesses an efficient antioxidant ac tivity. Indeed, brain tissue contains various types of an tioxidants, some of them unique to the brain. The anti oxidant system can be classified into two major groups: enzymes and LMW A. The enzymes include a limited number of proteins: superoxide dismutase (SOD), cata lase and peroxidase, as well as some supporting en zymes. The levels of the enzymes vary in different brain regions and among various species. Whereas the activity of SOD, which dismutes superoxide radicals to hydrogen peroxide, is quite high, the activity of catalase, acting to degrade hydrogen peroxide to water and oxygen, is rela tively low (Sinet et a!., 1980; Reiter 1995) . Rat brain contains high levels of glutathione peroxidase, which re moves hydrogen peroxide. There are also some support ing enzymes that act indirectly as antioxidants. For ex ample, glucose-6-phosphate dehydrogenase supplies NADH molecules which, in turn, can regenerate gluta thione to its active form. The role of the endogenous antioxidant enzymes in acute central nervous injury was shown by Chan et al. in genetically manipulated mice. Transgenic mice that overexpress CuZn-SOD and anti apoptotic Bcl-2 in the brain were found to be protected in a model of brain ischemiaireperfusion injury, whereas knockout mutants, deficient in SOD, were more vulner able to the same type of injury (Chan, 1996) .
The LMW A group of molecules can be further clas sified into indirect-acting (e.g., chelating agents) and di rect-acting antioxidants (e.g., scavengers and chain breaking antioxidants). The latter antioxidants are ex tremely important in combating against oxidative stress. This subgroup contains several hundred compounds that originate in a number of sources (both endogenous and exogenous). However, only a minority of these mol ecules, such as glutathione, NAD(P)H and carnosine, are synthesized by the cell itself. The majority of the anti oxidants, including ascorbic acid, lipoic acid, polyphe nols, and carotenoids, are derived from dietary sources. Another source of LMW A is the waste products of the living cell (such as uric acid), which were also shown to possess antioxidant properties (Ames et aI., 1981 (Ames et aI., , 1993 .
Major low-molecular weight antioxidants in the brain. Glutathione. This tripeptide (glu-cys-gly) is the most abundant nonprotein thiol found in the brain. Glutathione acts as an antioxidant via its capacity to serve as a sub strate for the enzyme glutathione peroxidase. According to in vitro studies, glutathione seems to be concentrated in astrocytes (Raps et aI., 1989) .
Tocopherols (vitamin E). Humans derive this vitamin from their diet. This lipid-soluble antioxidant, usually concentrated in the cell membrane, acts as a scavenger by donating an electron to peroxyJ radicals, thus prevent ing propagation of lipid peroxidation (Reiter, 1995) .
Ascorbic acid. Humans and other primates have lost the ability to synthesize ascorbic acid and they rely on dietary sources for this compound. Vitamin C is consid ered a powerful hydrophilic scavenger in biological flu ids and tissues (Frei et al. 1989) . It is distributed through out the brain and its concentration in the cerebrospinal fluid is about tenfold than in the plasma. The vitamin serves as a strong reducing agent by donating electron(s), thus directly neutralizing ROS, and it also acts to recycle the tocopherol radical to its active, reduced form. How ever, ascorbate may also acquire a strong pro-oxidant activity by reacting with iron ions in the so called "Udenfriend reaction" to produce highly toxic hydroxyl radicals (Brodie et aI., 1954) . This reaction might occur in the brain after injury, because of mobilization of iron ions and their interaction with ascorbic acid (Reiter, 1995; Halliwell and Guttering, 1989, Halliwell, 1996) .
Histidine-related compounds. Histidine dipeptides (carnosine, homocarnosine, and anserine), which are synthesized in the brain and muscle, are important anti oxidants, unique to these tissues. Their concentration in muscle and brain is relatively high (up to 20 mmollL) depending on the part of the brain and the animal species involved (Kohen et aI., 1988; Boldyrv et a!., 1987) . They act as chelating agents capable of binding transition met-10 10 E. SHOHAMI ET AL. als and preventing the involvement of the latter in the metal-mediated Haber-Weiss reaction. The dipeptides scavenge peroxyl and hydroxyl radicals, and bind hydro gen peroxide and remove it from targets susceptible to oxidative damage. These compounds can also interact with singlet-oxygen, mimic SOD, and show peroxidase like activity (Kohen at aI., 1991) .
Melatonin. N-acetyl-5-methoxytryptamine is pro duced in the pineal gland and readily passes through the blood-brain ' barrier (BBB) to enter neurons and glial cells (Reiter, 1995) . It is a potent scavenger , of peroxyl and hydroxyl radicals, prevents both initiation and propaga tion of lipid peroxidation, and stimulates brain glutathi one peroxidase. Melatonin can act as an antioxidant both in lipophilic and hydrophilic environments because of its solubility properties. Recently it was shown that mela tonin inhibits nitric oxide synthase, thus preventing the toxic effect obtained after its interaction with superoxide radicals (Reiter, 1995; Reiter et aI., 1994; Pozo et aI., 1994) .
Uric acid. Uric acid, a waste product of the living cell, produced by xanthine oxidase, is widely distributed in relatively high concentrations in the body. Urate contrib utes up to 60% of the total antioxidant activity of plasma in healthy subjects (Wayner et aI., 1987; Benzie, 1996) , acting as a preventive antioxidant by interacting with \0 to 15% of the hydroxyl radicals produced daily, and is an efficient scavenger of both peroxyl radicals and singlet oxygen (Ames et aI., 1981) . It also binds iron (Davies et aI., 1986) , and acts indirectly by stabilizing plasma ascorbate (Sevanian et aI., 1991) . In contrast, Benzie and Strain (1996) recently hypothesized that urate, at high concentrations, acts as a pro-oxidant, and suggested that because of pro-oxidant mechanisms, hyperuricemia is a risk factor for oxidative stress-associated disorders.
Lipoic acid. The lipid soluble dithiol a-lipoate is absorbed from the diet, crosses the BBB and is taken up by cells. It possess a wide spectrum of activity as a metabolic antioxidant, and its reduced form, dihydroli poate, exits the cells to act as an extracellular antioxi dant. a-lipoate scavenges hydroxyl radicals, hypochlo rous acid, nitric oxide and peroxynitrite, hydrogen per oxide, and singlet oxygen. It is also an effective chelator of transition metals, and may regenerate various antioxi dants such as ubisemiquinone, dehydroascorbate radical, and glutathione disulfide, to their active form. Thus, a-li poate and its reduced product act as potent antioxidants in both intra-and extracellular environments (see review Packer et aI., 1995) , and were recently reported to show neuroprotective properties in a variety of brain and neu ronal tissue pathologies (Packer et aI., 1997) .
The reducing antioxidant capacity of the brain One of the most important tools for evaluating the involvement of ROS in pathological disorders is quanti- 1997 fication of the antioxidant activity of the tested biological tissue. Most of the methods used to evaluate such anti oxidant activity determine specific scavengers, or are specific for the reactive species involved, and do not indicate the overall antioxidant status of the tissue (Rice Evans and Miller, 1994) . To overcome this difficulty, several methods designed to evaluate the overall antioxi dant activity of a biological tissue were developed. How ever, these methods suffer from severe disadvantages (Rice- Evans and Miller, 1994) . Measurement of antioxi dant enzyme activity is relatively easy because of the availability of well-characterized techniques for the de termination of the limited number of enzymes involved. However, evaluation of the total antioxidant activity de rived from LMW A is more difficult because of the large number of scavengers and the need for advanced labo ratory techniques for their quantification.
As previously described, LMW A that interact directly with ROS play a major role in defending the brain against oxidative damage and they possess several ad vantages over antioxidant enzymes. These molecules are relatively small and readily penetrate the cells, localizing at specific sites of oxidative stress, thereby supplying site-specific protection against site-specific oxidative damage. Low-molecular weight antioxidants display a wide spectrum of activity against a variety of ROS and they can be regenerated in the brain to their active form.
A review of the literature shows that there is no com prehensive review on the role of the overall activity of the direct-acting LMWA after traumatic brain injury and in pathological disorders.
The cyclic-voltammetry technique. The cyclic-vol tammetry technique has been used in chemistry to study electron transfer between molecules for a long time. Kissinger et al. (1973) suggested that this technique could be used to evaluate levels of antioxidants such as ascorbic acid, and by implantation of microelectrodes in rat brain they have showed that this methodology can be applied in vivo. Recently, we developed a new method that enables evaluation of the overall antioxidant activity derived from the LMWA in the brain as well as in other biological tissues and fluids. The new technique is based on a common chemical property of the direct-acting LMW A. Examination of the chemical nature of these compounds revealed that these agents are reducing equivalents that donate their electron(s) to the ROS. To date, the cyclic-voltammetry technique has been used in chemistry and biochemistry for measuring overall anti oxidant capacity. Therefore, we hypothesized that deter mination of the total reducing power of a biological fluid or tissue may indicate its antioxidant status, which is derived from LMW A. We have indeed verified this as sumption in many biological systems, including brain tissue (Kohen 1993; Kohen et aI., 1992; Chevion et aI., 1997) . To measure total reducing power we used a cyclic voltammeter. The measurements al lowed us to draw conclusions regarding the types of LMW A present in the brain (indicated by the oxidation potentials of the anodic waves, Fig. 1 ) and the total con centration of the LMWA (indicated by the anodic cur rent, Fig. 1 ) without measuring the specific compounds. Although specificity is an important issue when dealing with antioxidants, the brain, as other tissues or body fluids, contains a large number of such molecules, which may act in concert and synergistically with each other. Thus, by measuring levels of individual antioxidants one may obtain only a partial picture and overlook the whole tissue-reducing power, derived from LMWA. The sensi tivity limit of the cyclic-voltammetry methodology is in the range of I f,LmoIlL, allowing physiological levels of antioxidants to be readily determined (ascorbate 50 f,LmoIlL, uric acid-300 f,Lmol/L). Using cyclic-voltam metry methodology, we were able to evaluate both hy drophilic LMW A such as ascorbic acid, uric acid (first anodic wave), and NADH, carnosine (part of the second anodic wave) ( Fig. 1) , as well as lypophylic LMWA, including tocopherols and carotene (manuscript in prepa ration). In a complementary assay performed to confirm and quantify the cyclic voltameter measurements, we characterized specific LMW A composing the anodic waves by using an HPLC apparatus equipped with an electrochemical detector.
CLOSED-HEAD INJURY MODELS AND
STUDIES ON LOW-MOLECULAR WEIGHT
ANTIOXIDANTS
In the following sections we describe the results of our own studies on an experimental model of CHI developed in our laboratory for the rat (Shapira et aI., 1988) and, recently, for the mouse (Chen et aI., 1996) . This model can reproduce the posttraumatic sequelae observed in humans and some of the data obtained in this model are essentially similar to those observed in human head in jury (edema formation, BBB breakdown, motor and cog nitive dysfunction, etc.). In the posttraumatic period, we also showed activation of the arachidonic acid metabolic cascade (Shohami et aI., 1987 (Shohami et aI., , 1989 ) that produces free radicals, as well as enhanced cytokine production (Shohami et aI., 1994a) , a typical inflammatory response involving ROS. However, because of the extremely short half-lives of oxygen radicals, and methodological prob lems, there is no direct evidence for the production of ROS.
Reactive oxygen species in the pathophysiology of closed-head injury Two approaches were applied in our CHI model to the study of the role of ROS in posttraumatic events: The first is based on measuring of the total reducing capacity of brain tissue, using the cyclic-voltammetry technique A typical tracing of brain cyclic voltameter. E1121 denotes the oxidation potential (mV), and the anodic current denotes the total concentration of the molecules being oxidized at the par ticular potential.
(as described above). Here, changes in total tissue levels of LMW A ret1ect the consumption and/or recruitment of these molecules as an endogenous defense mechanism for neutralization of the ROS continuously produced af ter injury. We used this approach to compare the changes in brain LMW A in response to CHI in two models in which basic physiological changes might affect the abil ity to recruit LMW A: heat acclimation of rats, and apoE deficiency in mice. In both models, CHI was induced, and the clinical outcome was compared with that of their matched controls. The second approach is based on phar macological intervention aimed at neutralizing ROS. The beneficial effects on the outcome of CHI of (1) an iron chelator, (2) SOD, (3) a radical-neutralizing agent from the nitroxide family, and (4) a novel NMDA antagonist (HU-211), which possesses antioxidants properties, have been described and imply that cerebroprotection is, at least in part, caused by the prevention of oxidative dam age.
In cyclic-voltammetry tracings of brain extracts of wa ter-soluble LMW A, two anodic, component-specific waves, representing two classes of reducing equivalents, were identified at a potential of 350 ± 50 and 750 ± 50 m V. The first class consisted of ascorbate and urate and other unknown scavengers, and the second probably in cluded imidazole-containing molecules such as NADH, histidine, carnosine, and other histidine-related com pounds. After CHI, the nature of the LMW A was not altered, because the two anodic potentials remained ba sically unchanged. However, a nonsignificant shift was observed caused by variations in the relative contribu tions of the individual LMW A comprising the anodic wave. However, the anodic current, la, which represents the concentration of LMW A at any particular potential, was markedly affected. A biphasic response to CHI was measured in the traumatized rats, with an initial decrease (-40% at 5 minutes) followed by a transient increase (at 4 hours) and a second decrease at 24 hours (of -60%), followed by a return to the basal, pre-CHI level at 48 hours, which persisted up to 7 days. The significant de crease in the concentration of the reducing equivalents 5 minutes after CHI may be explained by their immediate utilization. This hypothesis is supporteq by the observa tion that ROS-neutralizing agents are cerebroprotective when administered soon after CHI (see below, and Beit Yannai et aI., 1996a). At 4 hours, the disruption of the BBB is maximal (Shapira et aI., 1993) , and high levels of LMW A originating in the plasma may accumulate in the damaged area. Because these compounds can then react with the ROS being produced via processes activated in the posttraumatic period (e.g., arachidonic acid metabo lism, inflammation), it is likely that their levels again decrease up to 24 hours after CHI. Similar biphasic changes in brain-reducing capacity levels were also found in the right (contralateral) hemisphere, suggesting that the trauma exerted a global effect on the reducing capacity 0\ the brain.
The correlation between the ability of the brain to increase low-molecular weight antioxidants and the clinical outcome of closed-head injury Effect of heat acclimation on the endogenous low molecular weight antioxidants profile. Effect on basal levels. A unique model for examining the role of endog enous antioxidant mechanisms in brain injury is heat acclimation, achieved by chronic exposure to moderate heat. Acclimation leads to adaptive metabolic changes, resulting in a lower metabolic rate (In bar et aI., 1975; Horowitz and Samueloff, 1989; Horowitz, 1994) , and improved work efficiency of the heart, accompanied by cardioprotection during ischemia and reperfusion (Horowitz et aI., 1993; Levi et aI., 1993 Levi et aI., , 1997 . In con trast, cold-acclimation was reported to increase the ac tivity of antioxidant enzymes such as SOD, catalse, total and selenium-dependent glutathione peroxidases, and gluthatione reductase in brown adipose tissue (Barja-de Quiroga et aI., 1991). It thus seems that the antioxidant enzymes are among the defense mechanisms that are regulated during the body's response to changes in en vironmental temperature.
When CHI was induced in heat-acclimated rats, they showed faster and better recovery of motor functions, as compared with that of normothermic rats subjected to a similar severity of injury (Shohami et aI., 1994b) . In addition, edema and BBB disruption were also signifi cantly lower in the heat-acclimated rats (Fig. 2) al. reported a reduction in the production of prostagladins by acclimated rats (1989) . Because the arachidonic acid pathway is activated by CHI and is known to produce free radicals, we speculated that attenuated production of ROS is part of the benefits gained by heat acclimation and results in a more favorable clinical outcome after CHI. Therefore we examined the total tissue-reducing equivalents in the brains of acclimated rats, in an attempt to correlate the observed protection with the ability of the brain to neutralize ROS.
A cyclic voltammetry study of the water-soluble frac tion of LMW A revealed that the acclimated rats dis played anodic potentials similar to those of the normo thermic rats. Hence, the acclimation process had not changed the chemical nature of the LMW A present in the brain. However, the anodic current (la, which is propor tional to the concentration of reducing equivalents) of both potentials was lower (-60% of the control), i.e., the levels were significantly reduced.
In view of the abundance of uric acid and its dual activity, as anti-and pro-oxidant, we determined the lev els of uric acid (which appears at the first anodic poten tial in the voltagram), along with the activity of the en zyme catalyzing its production, xanthine oxidase, in brain extracts and in the serum of normothermic and heat-acclimated, nontraumatized rats. Unexpectedly, lower levels of uric acid were found in the brains as well as in the sera of acclimated rats as compared with those in the control rats. The brain xanthine oxidase activity of acclimated rats was also lower than in the control rats, indicating a lower rate of uric acid synthesis after heat acclimation (Beit-Yannai et aI., 1996b).
Effect of heat acclimation on the low-molecular
weight antioxidant profile after closed-head injury.
Despite lower levels of LMWA in the brain of heat acclimated rats, they did not display an immediate drop (at 5 minutes) in the levels of reducing equivalents after CHI, as opposed to normothermic rats. Moreover, at 4 hours and for up to 7 days, the levels were even signifi cantly higher (by -40 to 50%) at both oxidation poten tials than in the nontraumatized rats. The ratio between the anodic current at each interval after CHI and before injury was calculated. The relative changes in the anodic currents during the post-CHI period in the normothermic rats revealed a postinjury ratio of <l; namely, the level of LMW A was lower than in the sham rats. In contrast, the heat-acclimated rats displayed markedly higher levels during the entire posttraumatic period, maintaining a ra tio of > 1 for up to 7 days (Beit-Yannai et aI., 1997). Therefore, we suggested that heat acclimation potentiates a systemic mechanism that enables the rats to cope more efficiently with the additional acute stress of CHI and that, at least in part, long-term exposure to high ambient temperature provides a more efficient mechanism for The outcomes of closed-head injury (CHI) on clinical recovery, edema, and blood-brain barrier (BBB) integrity. Sham rats were anesthetized with ether, their scalp skin was incised, but trauma was not induced. Closed-head injury rats were sub jected to closed-head injury as described by Shapira et aI., 1988 . TPL-4-hydroxy-2,2,6,6,-tetramethylpiperidine-1-N-oxyl, a radical neutralizing agent of the nitroxide family was administered within 5 minutes of CHI (50 mg/kg, intravenously) as described (Beit Yannai et aI., 1996a) . Heat acclimated rats were maintained for 30 days at 34°C, before being subjected to CHI, as described by Shohami et aI., 1994 Water content of cortical tissue taken from the site of the impact 24 hours after CHI was (;alculated from the dry/wet weight ratio as described by Shapira et aI., 1988. (C) Effect of CHI on BBB integ rity. Evans Blue (2% weight to volume ratio in saline) was injected intravenously into sham or traumatized rats 3 hours after induc tion of CHI. One hour later, the animals were anesthetized and the dye was extracted and quantified as described by Shapira et aI., 1993) . ACC, heat acclimated rats; CHI, closed-head injury.
dealing with ROS. This seems to be a mUltiorgan pro cess, specific to the effect of heat acclimation, as both brain and heart share a similar response to CHI. Effect of ap olipoprotein E deficiency on the endog enous low-molecular weight antioxidant profile after closed-head injury. Apolipoprotein E is a 36-KD plasma glycolipoprotein that plays a key role in lipoprotein me tabolism by facilitating the cellular uptake of remnants of triglyceride-rich chylomicrons and very low-density li poproteins (Brewer et aI., 1989 , Mahley, 1988 . Apart from its role in facilitating plasma cholesterol transport, apoE is thought to participate in the mobilization and redistribution of lipids during the normal development of the nervous system and to play a key role in the regula tion of lipid metabolism after peripheral injury (Ignatius et aI., 1987) . Lomnitski et al. (1997) studied the antioxi dant capacity of apoE by incubating Cu+ 2 with f3-very low-density lipoproteins in the presence of recombinant human apoE3. They reported that Cu+ 2 -induced lipid peroxidation was retarded by apoE. Thus, apoE knockout mice might possess defective endogenous antioxidant mechanisms in addition to their impaired cholinergic function (Gordon et aI., 1995) . Epidemiological studies on Alzheimer's disease, the major cause of dementia in the elderly, have revealed the role of genetic and envi ronmental factors. These include the allele £4 of apoE (Roses, 1994) and head trauma (Gentleman et aI., 1993) , and there seems to be a synergistic relationship between the two genetic and environmental risk factors. There fore, apoE-deficient mice could serve as models for in vestigating the role of endogenous antioxidants in the recovery from CHI. Thus, the induction of CHI on ge netically susceptible mice might be a relevant model for Alzheimer's disease studies.
Indeed, using apoE-deficient mice, we recently showed that the recovery of the cognitive and neurologi cal functions of these mice after CHI was slower than that of control mice (Chen et aI., 1997) . These derange ments were associated with more pronounced neuronal cell death in the hippocampus of the apoE-deficient mice. Therefore, we speculated that the increased sus ceptibility of the apoE-deficient mice to CHI could be caused by the dysfunction of their neuronal, and prob ably other, brain-repair mechanisms, suggesting that these mice lack, at least in part, an endogenous antioxi dant mechanism(s). In line with this supposition, Lom nitski et al. (1997) showed, using cyclic voltammetry, that although nontraumatized mice, both control and apoE-deficient, have similar levels of reducing equiva lents, they differ markedly in their response to CHI. Al though a biphasic response to CHI was measured in both groups of traumatized mice, the initial decrease (at 5 minutes after injury) and the subsequent increase (at 4 hours) were significantly less pronounced in the apoE deficient mice. Under similar conditions, these mice were unable to mobilize antioxidants to the same extent as the controls. The lower anti oxidative response of the brain to CHI in apoE-deficient mice suggests that this phenomenon may play a role in their impaired ability to recover from brain injury. Furthermore, these findings support the notion of a synergistic relationship between genetic and environmental risk factors in neurodegenera ti ve diseases such as Alzheimer's disease.
Pharmacological approach: effect of reactive oxygen species-neutralizing agents on the outcome of closed-head injury Therapeutic strategies aimed at decreasing brain injury have included the administration of radical scavengers at the time of reperfusion. The rationale for this treatment is that if ROS are instrumental in mediating biological damage, their rapid removal should afford protection. A LMW A, like tirilazad mesylate (U-74006F), one of the most efficacious inhibitors of lipid peroxidation, was shown to ameliorate postischemic neurologic deficits and to protect against ischemic brain damage (Xue et aI., 1992) . Spin traps, such as nitrones, have also been re ported to be effective neuroprotectants in a variety of brain injury models (Hensley et aI., 1997) . In contrast, the efficacy of traditional oxygen radical scavenger en zymes such as superoxide dismutase (SOD) and catalase is limited by their inability to cross the BBB and pen etrate the cells (Chan et aI., 1987; Imaizumi et aI., 1990) .
Des feral: an iron-chelating agent. Desferal, a potent chelator of redox-active metals, was shown to alleviate brain edema in a variety of brain injury models (e.g., Ikeda et aI., 1989) . In our model of CHI, when admin istered within 5 minutes after injury, desferal facilitated the clinical recovery of traumatized rats and markedly reduced edema (Zhang et aI., 1997) . By specific iron staining of brain sections, we recently found that tissue injury leads to iron mobilization and to an increase in free chelateble iron pools (unpublished finding). Thus, our observations on the protective effect of an iron chelating agent in the present model of CHI agree with those reported by Ikeda et ai. (1989) and by White and Krause (1993) , and support the role played by redox active transition metals in the pathophysiology of CHI.
Superoxide dismutase. The administration of recom binant human SOD (r-h-MnSOD, a gift from Biotech nology General. Ltd. Rehovot, Israel) to traumatized rats within minutes of CHI, had some beneficial effects, mainly on survival and clinical recovery. However, the effect on edema or on BBB was moderate and insignifi cant (Zhang et aI., 1997) . It should be noted that the nonpenetrable enzyme SOD could enter the brain paren chyma because in our CHI model, BBB is disrupted within minutes of injury (Shapira et aI., 1993) . There fore, our findings suggest that extracellular O2 is in- Vol. 17, No. 10, 1997 volved in the pathological events after CHI, and that SOD, by neutralizing these radicals, facilitates clinical recovery. However, the effect of exogenous SOD is lim ited as it cannot penetrate the cells. To overcome this limitation, polyethylene glycol-conjugated SOD was pre pared and used in humans with head injuries (Muizelaar et aI., 1994) and experimental animals (Hamm et aI., 1996; Muir et aI., 1995) . These studies showed that neu tralization of superoxide radicals has a beneficial effect on functional outcome and cerebral blood flow after trau matic injury, implicating that these radicals play a role in the pathophysiology of brain trauma.
Nitroxides as antioxidants. A complementary strategy of intervention with the overproduction of ROS involves the use of stable nitroxide radicals and has been applied to the protection of cells (Krishna et aI., 1994; Samuni et aI., 1991a; 1991b) , organs (Gelvan et aI., 1990) , and whole animals (Hahn et aI., 1992) from diverse insults. Nitroxides, which are cell-permeable, nontoxic, nonim munogenic stable radicals, have been used as biophysical probes for monitoring membrane stability, cellular pH, oxygen concentration, and intracellular redox reactions, or as contrast agents for nuclear magnetic resonance im aging. These compounds undergo a one electron redox reaction and catalyze the dismutation of O2 radicals. They can also reduce hypervalent metals and catalyti cally facilitate H202 dismutation by hemeproteins (Krishna et aI., I 996a, 1996b) . Previous studies showed that nitroxides are capable of preventing lipid peroxida tion, (possibly occurring as a result of CHI), which is mediated by ROS (Pogrebniak et aI., 1991) , to selec tively detoxify paramagnetic species including radicals and transition metals. Studies of bacterial and cultured mammalian cells revealed that nitroxides provide cyto protection from the toxicity induced by H202 and by tumor necrosis factor (Samuni et aI., 1991a; 1991b) . In our model of CHI, nitroxides were also found to mark edly improve the outcome, as shown by the facilitated clinical recovery, reduced edema and protection of the BBB (Fig. 2) , and to have a therapeutic window in the range of 4 hours after CHI (Beit-Yannai et aI., 1996a , Zhang et ai. 1997 .
The mechanism underlying nitroxide activity. Ni troxides display SOD-like activity because they are able to penetrate the cell and to neutralize intracellular radi cals. As such, nitroxides can serve as protective agents both intra-and extracellularly. Whereas the reaction of ROS with endogenous diamagnetic molecules present in the body gives rise to secondary radicals, radical-radical reactions are rapid and often result in diamagnetic non toxic species. According to the m � chanism underlying the reaction of nitroxides with O2' , the removal of su peroxides is a catalytic process. By undergoing one electron transfer reactions, nitroxides shift between three oxidation states and their concentration does not change with time. In addition, the release of iron from ferritin is probably one of the consequences of brain injury, and nitroxides may also interfere with this destructive path way (unpublished observation). Thus, the cerebroprotec tive effecs of nitroxides, along with their multiple action (termination of radical-chain reactions, oxidation of del eterious metal ions and removal of intra-and extracellu lar superoxide) support the notion that ROS are indeed involved in the deleterious events occurring after trauma.
Dexanabinol (HU-21I), an NMDA antagonis t and anti-oxidant. Dexanabinol (HU-211), a synthetic canna binoid (+ )-(3S,4S)-7 -hydroxy-Ll-6 tetrahydrocannabinol 1,1-dimethylheptyl, is inactive as a cannabimimetic but shows pharmacological properties characteristic of N methyl-D-aspartate (NMDA)-receptor antagonists. In binding studies with 3 H-TCP and 3 H-MK-801, it has been shown to block NMDA-receptors stereospecifically by interacting with a site close to but distinct from that of noncompetitive NMDA-receptor antagonists and from the recognition sites of glutamate, glycine and poly amines (for review see Shohami et aI., 1996) . In addition to the antagonistic properties of HU-211 to the NMDA receptor, Eshhar et al. (1995) reported that the drug res cued neurons in culture from injury evoked by sodium nitroprusside, hydrogen peroxide, and oxygen-glucose deprivation. It also reduced protein oxidation initiated by gamma irradiation and scavenged ROS. Based on these findings, it was suggested that in the presence of radicals, HU-211 can also act as an antioxidant or as a radical scavenger, and not purely as a noncompetitive antagonist of the NMDA receptor. Moreover, we recently showed that HU-211 also inhibits the production of tumor necro sis factor (Shohami et aI., 1997) , thus also blocking the signal transduction pathway that activates the NFKB. In a series of studies we and other investigators have shown that HU-211 is a very potent cerebroprotectant in models of cerebral ischemia, CHI, experimental meningitis, and optic nerve crush (for review see Shohami et aI., 1996) . A comparison of the cerebroprotective effect of HU-211 with that of another well-studied NMDA antagonist (MK-80 1), revealed that in our model of CHI, MK-80 1 is less effective and its sedative effects are too pronounced to allow it to be considered as a potential therapeutic agent (Shapira et aI., 1990) , whereas HU-211 is devoid of any psychotropic influence, and exerts long-term pro tective effects (Shohami et aI., 1993) . In all the above mentioned models, the activation of four deleterious pathways is involved in the delayed posttraumatic dam age: glutamate excitotoxicity, intracellular calcium accu mulation, cytokine production, and free radical forma tion. These pathways are probably interconnected. Therefore, we suggested that the cerebroprotective activ ity of HU-211, stems from the synergism between its multiple mechanisms of action and inhibitory effect on all four pathways.
SUMMARY
The present review focuses on a novel approach for investigating the temporal changes in endogenous LMWA in terms of total tissue response to injury. Two mechanisms are concomitantly activated in the brain fol lowing CHI: one involves the production of ROS; the other is a tissue response to the enhanced production of these destructive mediators. "Which is the most damag ing ROS" or "which is the most active endogenous antioxidant" may not be the questions at issue in the context of posttraumatic mechanisms because these mol ecules may act synergistically with each other. In addi tion, there is an interconversion between the reactive species, as well as between the endogenous antioxidants. Therefore, we believe that the present approach, which, to the best of our knowledge, is the first attempt to mea sure the total capacity of brain tissue to neutralize ROS, is valid under normal, and even to a larger extent, under pathological conditions. Further studies on the temporal changes of the individual antioxidants after CHI, are in progress in our laboratory. Figure 3A summarizes the "radical approach" to the role of ROS and of the LMW A endogenous defense mechanism in determining the clinical outcome of CHI. The extent of the final damage, comprising a number of physiological (BBB disruption, edema etc.) and behav ioral (motor and cognitive dysfunction) parameters, de pends on a delicate balance between the autodestructive and protective mechanisms triggered by the initial injury. The simplified scheme suggests that the production of ROS is common to a number of biochemical routes that have been shown to be activated in a variety of traumatic and ischemic brain injury models. These involve the eicosanoid cascade (via phospholipase A2), activation of the NMDA receptor, accumulation of intracellular Ca, and the release of cytokines. Each of these pathways has been found to be activated in brain injury, and numerous attempts to develop agents that block one or more of these pathways have been reported. Nevertheless, be cause the cascade of events is not linear, and all these pathways are activated in parallel, and result in the pro duction of ROS, it is likely that inhibition of ROS would prove effective in clinical trials.
We have tried to shed some light on the role of LMW A as one of the responses of the brain to overpro duction of ROS. Antioxidant enzymes have not been discussed in this context, although they may play an important role in combating ROS, as was shown by Chan (1996) . The biphasic pattern of changes in LMW A sup ports the hypothesis that injured animals indeed use their stores of LMW A in an attempt to neutralize ROS and to protect the injured tissue. Two physiological manipula tions were used in the studies reviewed here to support the notion that the more favorable outcome of CHI is concentration as part of its defense mechanism. The final outcome is determined by the balance between the concomitantly activated destructive and protective processes. (8) Under control conditions, CHI leads to changes in brain LMWA levels and to damage, depending on species, severity of injury, etc. (I) Acclimated rats are able to increase LMWA after CHI to higher levels than their matched controls, leading to a more favorable outcome, i.e., less damage (II). The increase in LMWA after CHI in apolipoprotein E-deficient mice is lower than in the controls, and the damage is greater (balance III). BBB, blood-brain barrier; Ca(in), intracellular free calcium; EAA, excitatory amino acids; LMWA, low-molecular weight antioxidants; PLA2, phospholipase A2; ROS, reactive oxygen species.
associated with a better ability to neutralize ROS, namely to elevate endogenous LMW A after trauma. As shown in Fig. 3B , in heat-acclimated rats, higher levels of LMW A were found after CHI, than in their matched controls, and the incurred damage was accordingly reduced. The apoE knockout mice, which displayed impaired recruitment of LMW A, showed slower recovery and greater damage. In short, the greater the LMW A response, the better the outcome after CHI. Whereas nitroxides act only by terminating radical chain reactions, HU-211 displays multiple mechanisms of action, and heat acclimation triggers physiological adaptive mechanisms, some involving LMW A. The ben eficial effects of heat acclimation, HU-21I, and nitroxide indeed suggest that in our CHI model the most favorable outcome is achieved when treatment is based on more than one mode of action. Our findings indicate that clini cal therapy could prove more effective by combining J Cereb Blood Flow Metab. Vol. 17. No. 10. 1997 antioxidant therapeutic principles with other protective mechanisms.
